BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12552944)

  • 1. Prognostic value of glucose transporter 1 expression in patients with hypopharyngeal carcinoma.
    Mineta H; Miura K; Takebayashi S; Misawa K; Araki K; Misawa Y; Ueda Y
    Anticancer Res; 2002; 22(6B):3489-94. PubMed ID: 12552944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness.
    Kato H; Takita J; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(5):2635-9. PubMed ID: 12529975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of GLUT-1 in the invasion front is associated with depth of oral squamous cell carcinoma and prognosis.
    Ohba S; Fujii H; Ito S; Fujimaki M; Matsumoto F; Furukawa M; Yokoyama J; Kusunoki T; Ikeda K; Hino O
    J Oral Pathol Med; 2010 Jan; 39(1):74-8. PubMed ID: 19709351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma.
    Fenske W; Völker HU; Adam P; Hahner S; Johanssen S; Wortmann S; Schmidt M; Morcos M; Müller-Hermelink HK; Allolio B; Fassnacht M
    Endocr Relat Cancer; 2009 Sep; 16(3):919-28. PubMed ID: 19465749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin 7 (p53-induced gene 1): a new prognostic predictor of recurrence and survival in stage IV hypopharyngeal cancer.
    Saussez S; Cucu DR; Decaestecker C; Chevalier D; Kaltner H; André S; Wacreniez A; Toubeau G; Camby I; Gabius HJ; Kiss R
    Ann Surg Oncol; 2006 Jul; 13(7):999-1009. PubMed ID: 16788763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of tumor volume in patients with stage III-IVA hypopharyngeal cancer without bulky lymph nodes treated with definitive concurrent chemoradiotherapy.
    Chen SW; Yang SN; Liang JA; Lin FJ; Tsai MH
    Head Neck; 2009 Jun; 31(6):709-16. PubMed ID: 19260114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
    Kim CH; Kim J; Kahng H; Choi EC
    Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression and prognostic significance of FAS and GLUT1 in bladder carcinoma.
    Visca P; Sebastiani V; Pizer ES; Botti C; De Carli P; Filippi S; Monaco S; Alo PL
    Anticancer Res; 2003; 23(1A):335-9. PubMed ID: 12680233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival.
    Younes M; Juarez D; Lechago LV; Lerner SP
    Anticancer Res; 2001; 21(1B):575-8. PubMed ID: 11299807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preliminary research of the relationship between overexpression of facilitative glucose transporter-1 and fluorodeoxyglucose uptake in primary human lung squamous cell carcinoma].
    Wang T; Sun YE; Tian JH; Liu XB; Yao SL; Wang K
    Zhonghua Wai Ke Za Zhi; 2003 Dec; 41(12):913-6. PubMed ID: 14728832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of glucose transporter 1 in gastric carcinoma and metastatic lymph nodes and its association with prognosis].
    Wei B; Chen L; Li J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):277-80. PubMed ID: 19434538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glut3 expression in biopsy specimens of laryngeal carcinoma is associated with poor survival.
    Baer S; Casaubon L; Schwartz MR; Marcogliese A; Younes M
    Laryngoscope; 2002 Feb; 112(2):393-6. PubMed ID: 11889403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of proliferating cell nuclear antigen expression with the clinical and biological characteristics and prognosis of hypopharyngeal carcinoma.
    Yao LS; Li XP; Li Q; Zhang JH
    Di Yi Jun Yi Da Xue Xue Bao; 2002 May; 22(5):448-50. PubMed ID: 12390713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
    Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
    Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microregional expression of glucose transporter-1 and oxygenation status: lack of correlation in locally advanced cervical cancers.
    Mayer A; Höckel M; Wree A; Vaupel P
    Clin Cancer Res; 2005 Apr; 11(7):2768-73. PubMed ID: 15814659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GLUT1 expression in human breast carcinoma: correlation with known prognostic markers.
    Younes M; Brown RW; Mody DR; Fernandez L; Laucirica R
    Anticancer Res; 1995; 15(6B):2895-8. PubMed ID: 8669885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
    Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.
    Spataro VJ; Litman H; Viale G; Maffini F; Masullo M; Golouh R; Martinez-Tello FJ; Grigolato P; Shilkin KB; Gusterson BA; Castiglione-Gertsch M; Price K; Lindtner J; Cortés-Funes H; Simoncini E; Byrne MJ; Collins J; Gelber RD; Coates AS; Goldhirsch A;
    Cancer; 2003 Apr; 97(7):1591-600. PubMed ID: 12655514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.